Loading…

Synthesis and Pharmacology of Willardiine Derivatives Acting as Antagonists of Kainate Receptors

The natural product willardiine (8) is an AMPA receptor agonist while 5-iodowillardiine (10) is a selective kainate receptor agonist. In an attempt to produce antagonists of kainate and AMPA receptors analogues of willardiine with substituents at the N 3 position of the uracil ring were synthesized....

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2005-12, Vol.48 (24), p.7867-7881
Main Authors: Dolman, Nigel P, Troop, Helen M, More, Julia C. A, Alt, Andrew, Knauss, Jody L, Nistico, Robert, Jack, Samantha, Morley, Richard M, Bortolotto, Zuner A, Roberts, Peter J, Bleakman, David, Collingridge, Graham L, Jane, David E
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The natural product willardiine (8) is an AMPA receptor agonist while 5-iodowillardiine (10) is a selective kainate receptor agonist. In an attempt to produce antagonists of kainate and AMPA receptors analogues of willardiine with substituents at the N 3 position of the uracil ring were synthesized. The N 3-4-carboxybenzyl substituted analogue (38c) was found to be equipotent at AMPA and GLUK5-containing kainate receptors in the neonatal rat spinal cord. The N 3-2-carboxybenzyl substituted analogue (38a) proved to be a potent and selective GLUK5 subunit containing kainate receptor antagonist when tested on native rat and human recombinant AMPA and kainate receptor subtypes. The GLUK5 kainate receptor antagonist activity was found to reside in the S enantiomer (44a) whereas the R enantiomer (44b) was almost inactive. 5-Iodo substitution of the uracil ring of 44a gave 45, which was found to have enhanced potency and selectivity for GLUK5.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm050584l